U.S. Markets closed

Empower Clinics Inc. (CBDT.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.6000-0.1600 (-21.05%)
At close: 3:59PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7600
Open0.6200
Bid0.5900 x 0
Ask0.6000 x 0
Day's Range0.5600 - 0.6700
52 Week Range0.0300 - 2.5000
Volume8,689,904
Avg. Volume2,410,726
Market Cap117.746M
Beta (5Y Monthly)3.45
PE Ratio (TTM)N/A
EPS (TTM)-0.0320
Earnings DateAug 14, 2019 - Aug 15, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Empower Clinics Provides Bi-Weekly Update on Status of Management Cease Trade Order

    VANCOUVER, BC / ACCESSWIRE / June 15, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is providing this bi-weekly update on the status of the management cease trade order granted by the British Columbia Securities Commission on May 3, 2021.

  • ACCESSWIRE

    Empower Clinics Signs Six Agreements for New Clinic Locations with National Pharmacy Group

    Clinic buildouts to commence in Ontario, Canada with annualized revenues for the six locations estimated between $12 million and $18 million CADVANCOUVER, BC / ACCESSWIRE / June 7, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens - is pleased to announce

  • ACCESSWIRE

    Empower Clinics Announces Major Expansion with Proposed Acquisition of Medisure Canada. Diabetes Tests and Devices Carried In 4,000 Pharmacies and Generated $1.9m in 2020 Revenue

    Acquisition Of Leading Canadian Diabetes Medical Device Company Significantly Expands Direct To Consumer Testing Products With 50,000 New End Users Supporting The Development Of The Kai Care Brand To North American MarketsVANCOUVER, BC / ACCESSWIRE / June 3, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (EPWCF:OTCQB) (8EC:Frankfurt) ("Empower" or the "Company") an integrated healthcare company serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics lab